We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bench-Top Robotic Cell-Free DNA Extraction Workstation Automates NIPT Workflows

By LabMedica International staff writers
Posted on 06 Sep 2023
Print article
Image: The MagBench automated DNA extraction instrument (Photo courtesy of Yourgene Health)
Image: The MagBench automated DNA extraction instrument (Photo courtesy of Yourgene Health)

Yourgene Health (Manchester, UK) has launched the Yourgene MagBench Automated DNA Extraction Instrument and Kit, designed to provide clinical laboratories with an efficient and cost-effective bench-top robotic workstation for cell-free DNA (cfDNA) extraction. This system is specifically optimized for Yourgene's Sage 32 NIPT Workflow, offering a comprehensive end-to-end solution, from sample handling to generating reports. This integrated approach enables clinical laboratories to offer a more accurate and competitive non-invasive prenatal testing (NIPT) service.

The Sage Prenatal Screen, a key component of this workflow, facilitates the safe and accurate genetic assessment of placental DNA in maternal blood using next-generation sequencing, delivering results within three days. The NIPT workflow begins with the extraction of DNA from maternal plasma using the MagBench instrument. Subsequent steps include library preparation, enrichment, sequencing, and Sage Link analysis, which estimates the risk of fetal trisomy 21, 18, or 13, rare autosomal aneuploidies, sex chromosome aneuploidies, and clinically significant microdeletions.

The MagBench Automated DNA Extraction Instrument is user-friendly, quick to install, and features an intuitive touchscreen interface with pre-programmed protocols. It offers efficient run times and flexible sample throughput to meet the laboratory's testing requirements. The MagBench Extraction Kit includes sample and elution tubes, pre-sealed cartridges containing all necessary reagents for cfDNA purification, and individually packaged tip sets with a unique cross-notch design to ensure precise volume pipetting. This system enhances the automation of DNA extraction, reducing manual intervention and the risk of human error. Additionally, it incorporates single-use tip disposal and a built-in UV lamp for decontamination between runs, thereby minimizing the potential for cross-contamination. These features collectively contribute to improved pipetting accuracy and consistency, resulting in a reduced failure rate. The MagBench solution is available to Sage customers in the Asia-Pacific and Middle East regions.

“Yourgene is committed to delivering best-in-class NIPT solutions, where precision and quality assurance are key,” said Dr. Rob Henke, Vice President of Sales, Asia-Pacific at Yourgene Health. “MagBench enables an economical and automated NIPT workflow. Reducing manual procedures improves user experience, facilitating true walkaway time while minimizing the risk of contamination and improving testing accuracy. This decreases the number of screening failures, greatly improves efficiency, and helps lower expectant parents’ anxiety.”

Related Links:
Yourgene Health

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.